Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Meet our Council: Loraine Roux – a proud Kovsie ambassador

2016-07-01

“I strive to represent the alumni
actively as an interest group,
and to help build the university
through sound business principles.”

Loraine Roux (née Kriek), former President of the Student Representative Council, was elected to the Council of the University of the Free State (UFS) in 2012. This former Kovsie made her mark at the UFS. Many staff members and former students will remember her as the beautiful brainbox, who achieved success in so many different areas of student life and humanity.

Loraine’s studies

Her journey as a Kovsie started as finalist in the prestigious Matriculant of the Year competition. Later, she obtained a Bachelor’s degree in Consumer Science at the UFS. Loraine, a born leader, was also Prime of Soetdoring residence, and remains the only student in the history of the university to be chosen as SRC President, Rag Queen, and Dux student in the same year.

After university

The Kriek family are all stalwart former Kovsies, with three generations – Loraine, her late grandfather Johan Kriek, and godparents, Rhyno and Mariette Kriek – having served on the Student Representative Council. So, it is no surprise that a leading firm like Deloitte & Touche noticed Loraine’s unique talent and leadership skills, and snatched her up for their CEO Bootcamp immediately after university.

Serving on the UFS Council

Currently, she is part of the team that is extending Deloitte & Touche’s ethical and fraud prevention services across Africa and Europe. She also uses her expertise and experience in risk management, ethical practice, and good corporate governance for her role as UFS councillor. As part of her duties as Alumni representative in the Council, she serves on the Naming Committee, as well as on the Audit and Risk Committee.

“It is a great privilege for me to serve on the Council, but it is also a great responsibility,” she says. “I strive to represent the alumni actively as an interest group, and to help build the university through sound business principles.”

Loraine married Gabriel Roux in 2014, and the couple live in Stellenbosch.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept